Dopamine- and serotonin-related grey matter atrophy in patients with Alzheimer’s disease and psychosis

Abstract Polygenic risk scores for schizophrenia (SCZ-PRS) may represent risk factors for psychotic symptoms in Alzheimer’s disease (AD). Since dopamine (DA) and serotonin (5HT) have been implicated in psychosis, this study investigated grey matter volume (GMV) loss associated with atlas-derived DA and 5HT distribution in AD-related psychosis and the relationship with a SCZ-PRS. Data of 98 patients with AD and psychosis (PT-PS) and 308 without psychosis (PT-NP), all amyloid-positive, were selected from the Alzheimer’s Diseases Neuroimaging Initiative. T1-weighted MRI scans were pre-processed with JuSpace to quantify the association between regional GMV and atlas-derived DA/5HT distributions. Generalised linear models were used to test the association between a SCZ-PRS and neurotransmitter-GMV correlation coefficients. PT-PS patients had smaller GMV than PT-NP in areas where 5HT1b receptor distribution is lower and D2 receptor and DA transporter distribution are higher. GMV alterations were primarily in medio-temporal areas, but the SCZ-PRS was not associated with GMV-neurotransmitter correlations. Although this study assessed neurotransmitter dysfunction indirectly via atlas-based estimates and findings are correlational, they offer insights complementary to previous evidence on the neurobiological underpinning of AD-related psychosis. Further investigations are needed to replicate these findings and to test the mechanistic involvement of neurotransmitters in AD-related psychosis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-12
DOI
https://doi.org/10.1038/s41598-026-75676-w
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dopamine- and serotonin-related grey matter atrophy in patients with Alzheimer’s disease and psychosis

Antonio F. Pardiñas, Riccardo Manca, Annalena Venneri
Scientific Reports
Dementia and Cognitive Impairment Research
article

Dopamine- and serotonin-related grey matter atrophy in patients with Alzheimer’s disease and psychosis

Antonio F. Pardiñas, Riccardo Manca, Annalena Venneri
article en

Abstract

Abstract Polygenic risk scores for schizophrenia (SCZ-PRS) may represent risk factors for psychotic symptoms in Alzheimer’s disease (AD). Since dopamine (DA) and serotonin (5HT) have been implicated in psychosis, this study investigated grey matter volume (GMV) loss associated with atlas-derived DA and 5HT distribution in AD-related psychosis and the relationship with a SCZ-PRS. Data of 98 patients with AD and psychosis (PT-PS) and 308 without psychosis (PT-NP), all amyloid-positive, were selected from the Alzheimer’s Diseases Neuroimaging Initiative. T1-weighted MRI scans were pre-processed with JuSpace to quantify the association between regional GMV and atlas-derived DA/5HT distributions. Generalised linear models were used to test the association between a SCZ-PRS and neurotransmitter-GMV correlation coefficients. PT-PS patients had smaller GMV than PT-NP in areas where 5HT1b receptor distribution is lower and D2 receptor and DA transporter distribution are higher. GMV alterations were primarily in medio-temporal areas, but the SCZ-PRS was not associated with GMV-neurotransmitter correlations. Although this study assessed neurotransmitter dysfunction indirectly via atlas-based estimates and findings are correlational, they offer insights complementary to previous evidence on the neurobiological underpinning of AD-related psychosis. Further investigations are needed to replicate these findings and to test the mechanistic involvement of neurotransmitters in AD-related psychosis.

Scientific Reports
University of Parma (IT), Cardiff University (GB), University of Sheffield (GB)
European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca, Research Executive Agency, NextGenerationEU
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon